Uncategorized Archives - Page 94 of 112

MondayJul 23, 2018 11:20 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Proceeding with Reorgani-zation into Four Subsidiaries

LXRP’s patented DehydraTECH technology will be employed by each wholly owned subsidiary, with applications applied to the industry segments At its 2018 Annual General and Special Meeting (AGM), all motions were passed, including election of board members and approval of its conversion plan Move to convert the company from a U.S.-based firm to Canada-based is placed on ‘indefinite hold’ due to inequitable tax treatment issue; LXRP to seek a resolution At Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) 2018 Annual General Meeting, all motions were passed. The company is proceeding on schedule with its reorganization into four new wholly owned…

MondayJul 16, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO Outlines Next Steps for Promising New Technologies

Company is targeting $3.8 trillion preventative medicine industry Sol-gel delivery system administers CBD-based medicines directly to the brain via nasal passages Company R&D includes anti-diabetes and obesity gene therapy and powerful non-addictive painkiller Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) expects to make promising progress in the research and development of a number of exciting products in 2018, according to the company’s chairman, CEO and President Stephen Van Deventer in an audio interview (http://cnw.fm/7CrAF). He explained that, while pharmaceutical and nutraceutical companies are well-established, there is a relatively untapped $3.8 trillion a year industry in preventative…

FridayJul 13, 2018 12:43 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Spinoff Canadian Assets to Unlock Underlying Value

New Canadian assets to be listed on the Toronto Stock Exchange and Nasdaq Sunniva’s U.S. assets to remain listed on the Canadian Securities Exchange (CSE) under the ticker symbol ‘SNN’ Two-year contract signed with industry leading Canopy Growth Corp. for 45 percent of production at Sunniva Canada Campus in British Columbia Sunniva anticipates launching its first line of Sunniva-branded products in the U.S. in Q3 2018 Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis company headquartered in Vancouver, Canada, and operating in the world’s two largest cannabis markets – Canada and California – is reaping positive attention with the…

ThursdayJul 05, 2018 1:03 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Chronic Disease, Preventive Healthcare Market

Global preventive healthcare technologies and services market expected to reach $432 billion by 2024 Centers for Disease Control (CDC) states that seven out of 10 U.S. deaths are caused by chronic diseases such as diabetes, with global cost of treating diabetes reaching $776 billion within two decades World Health Organization recommended in December 2017 that cannabidiol (CBD) should not be scheduled as a controlled substance, citing its potential as a beneficial pharmaceutical PreveCeutical’s CBD-based Sol-gel delivery platform offers ease of application, better bioavailability and controlled cannabidiol release PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), headquartered in Vancouver, British…

ThursdayJul 05, 2018 12:30 pm

Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) Seed to Sale Setup Sizzles in World’s Two Largest Cannabis Markets

Operating in world’s two largest cannabis markets – California and Canada Vertically integrated structure extracts value along the supply chain Pre-production sales strategy mitigates risk What can you give a company, like Vancouver, British Columbia-based Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), that seems to have everything? For starters, this vertically-integrated producer of medical and recreational cannabis has a presence in California and Canada, the world's two largest cannabis markets. Through several wholly-owned subsidiaries, it has operations in cannabis grow facilities, cannabis extraction facilities, medical cannabis clinics and the cannabis white label business. Moreover, a large part of its estimated total…

TuesdayJul 03, 2018 11:35 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues Advancing Innovative Drug Delivery Research Program

PreveCeutical is continuing its extensive research work on the Sol-gel CBD-based delivery system An expansion to Australia has enabled the company to run simultaneous tests on cannabis strains and delivery systems The scientific work is in line with a growing demand for cannabidiol and medicinal cannabis products Over the past few months, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has been working on the advancement of its innovative Sol-gel drug delivery research program. The focus of the research is to apply Sol-gel technology to develop cannabinoid-based therapies for the relief of symptoms associated with pain, inflammation, seizures and…

MondayJul 02, 2018 1:13 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Closes Purchase of Canadian Cannabis Campus; Facility Construction Advances

Sunniva acquires 126-acre property for cannabis production in British Columbia Construction at sibling cultivation site in California continues Company hosts VIP event at International Cannabis Business Conference, joins M&A panel discussion Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a rising cannabis producer that is gaining a solid foothold in the consumer-populated markets of California and Canada, has announced the close of its 126-acre site in British Columbia’s rural Okanagan Falls-Similkameen district located 45 kilometers (28 miles) north of the U.S.-Canada border. The 126-acre industrial-zoned property will be the site for a 740,000-square-foot state-of-the-art greenhouse capable of producing an estimated 100,000 kilograms…

ThursdayJun 28, 2018 12:59 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Floats on Rising Vaporizer Trends

Smoking as a delivery method faces increasing stigma Vaporization set to be a major smoking alternative Sunniva signs contract to supply extraction services to award winning cannabis brand Heightened awareness of the dangers posed by smoking is shaping the fast-developing cannabis marketplace. Smoking, the delivery vehicle of the tobacco industry, is playing a much lesser role. Nicotine may not kill – indeed, it is thought to have some health benefits – but smoking will. So, as markets for adult recreational use of marijuana open up across the U.S., alternative delivery technologies are expected to take center stage. Particularly popular is…

TuesdayJun 26, 2018 12:12 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Pursuing Diverse Applications for DehydraTECH™ Licensing

Lexaria will license in any of the 40 countries where its technology already has a patent or is patent-pending Company sees up to 80 percent of its future revenues coming from licensing DehydraTECH proprietary ingestion delivery technology DehydraTECH™ has applications for processed foods, tobacco industry, pharmaceutical companies, NSAIDs, supplements and beverages Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has a wide variety of licensing applications for its patented DehydraTECH™ delivery technology. It is already licensed to Nuka Enterprises LLC, maker of “1906” brand cannabis chocolates (http://cnw.fm/HD4bm). Chris Bunka, CEO, emphasizes that his company’s technology applies to far more than just the…

TuesdayJun 26, 2018 11:37 am

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Focusing On Innovative Drug Delivery Technologies

Pivot offers unique proprietary drug delivery platform technologies Company has a strong intellectual property (IP) portfolio for the formulation and delivery of cannabinoids Company acquires licensing rights to patented Trivair™ nasal and pulmonary drug delivery system, also signs exclusive manufacturing agreement with Bio V Pharma Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is a biopharmaceutical company based in Vancouver, British Columbia. Pivot engages in the development and commercialization of premium cannabinoid-based nutraceuticals and pharmaceuticals. It does so utilizing unique drug delivery platform technologies. Pivot Pharmaceuticals’ wholly-owned medical cannabis products division is Pivot Green Stream Health Solutions Inc. (“PGS”).…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

Category: Uncategorized